Net sales for Q4 2025 increased by 18.1% year-over-year to $57.8 million, driven primarily by sales growth in China. Net sales for fiscal year 2025 decreased by 23.7% year-over-year to $239.4 million, largely due to distributor and channel inventory reductions in China during the first half of the year. The company reported a net loss of $(18.3) million or $(0.37) per share for Q4 2025, an improvement from a net loss of $(34.2) million or $(0.69) per share in the prior year quarter. For fiscal year 2025, the net loss was $(80.4) million or $(1.62) per share, compared to a net loss of $(20.2) million or $(0.41) per share in fiscal year 2024. Adjusted EBITDA for Q4 2025 was breakeven, a significant improvement from a loss of $(20.8) million in Q4 2024. Adjusted EBITDA for fiscal year 2025 was a loss of $(6.6) million, compared to an income of $23.2 million in fiscal year 2024. Cash, cash equivalents, and investments available for sale totaled $187.5 million at January 2, 2026, down from $230.5 million at the end of Q4 2024. Operating expenses for Q4 2025 included $11.2 million related to the terminated Alcon merger and $0.7 million for restructuring. The company repurchased approximately 376,000 shares for $6.5 million under its $30 million share repurchase program, with $23.5 million remaining. Warren Foust and Deborah Andrews were appointed interim co-Chief Executive Officers on February 2, 2026, following the termination of the proposed merger with Alcon.